Abstract:A first derivative synchronous spectrofluorimetric technique is proposed for the simultaneous determination of celecoxib and tramadol, which are characterized by their overlapped spectra, in their coformulated mixture. The technique was successfully applied to their dosage form and spiked human plasma with satisfactory results and validated according to International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH). One of the most common features of many different clinical conditions is pain; hence, there is a crucial need for eliminating or reducing it to a tolerable level to retrieve physical, psychological and social functioning. A first derivative synchronous spectrofluorimetry technique is proposed for the simultaneous determination of celecoxib and tramadol HCl, a recent coformulation authorized for treating acute pain in adults. The method includes using synchronous spectrofluorimetry at ∆λ = 80 nm where tramadol HCl was determined using first derivative technique at λ = 230.2 nm, while celecoxib was determined at λ = 288.24 nm. The proposed method was successfully applied to their co‐formulated dosage forms in addition to spiked human plasma and validated in agreement with the guidelines of the International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH). The linear ranges were found to be 0.50–5.0 and 0.15–0.50, the limits of detection to be 0.088 and 0.011 and the limits of quantification to be 0.266 and 0.032 μg/ml for celecoxib and tramadol, respectively. Statistical analysis revealed no significant difference when compared with previously reported methods as evidenced by the values of the variance ratio F‐test and Student t‐test. The proposed method was successfully applied to commercial dosage forms and spiked human samples. Moreover, the greenness of the proposed method was investigated based on the analytical eco‐scale approach, with the results showing an excellent green scale with a score of 95.

Simultaneous determination of propacetamol and paracetamol by derivative spectrophotometry

Photochemically-Induced Fluorescence Of Paracetamol And Its Analytical Application

Spectrophotometric Determination of Paracetamol Using Diazotization Coupling Reaction

Simultaneous Determination of Paracetamol and Amantadine in Human Plasma and Bioequivalence of Its Preparations in Healthy Volunteers by LC-MS

Influence of medium and temperature on the hydrolysis kinetics of propacetamol hydrochloride: determination using derivative spectrophotometry

SIMULTANEOUS DETERMINATION OF PARACETAMOL/TRAMADOL AND ITS METABOLITE IN HUMAN PLASMA BY REVERSED-PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY

Quantification of ternary mixture of paracetamol, chlorzoxazone and ibuprofen present in tablet dosage form using ratio subtraction spectropohtometric approaches

Various techniques for resolving overlapping ultraviolet spectra of combination pharmaceutical dosage forms containing hydroxychloroquine and paracetamol

Quantification of ternary mixture of paracetamol, chlorzoxazone and ibuprofen present in tablet dosage form using ratio subtraction spectrophotometric approaches

Simultaneous Determination of Mycophenolic Acid and Valproic Acid Based on Derivatization by High-Performance Liquid Chromatography with Fluorescence Detection

Simultaneous Determination of Paracetamol and Caffeine in Human Plasma by HPLC

Simultaneous determination of emtricitabine and tenofovir disoproxil fumarate in pharmaceutical preparations using spectrophotometric, chemometric and chromatographic methods

A simple spectrophotometric method for the determination of captopril in pharmaceutical preparations using ammonium molybdate

First derivative synchronous spectrofluorimetric method for the simultaneous determination of tramadol and celecoxib in their dosage forms and human plasma

Agreement Between a Colorimetric Assay and Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry for Quantifying Paracetamol Plasma Concentrations

Simultaneous determination of paracetamol, pseudoephedrine, dextrophan and chlorpheniramine in human plasma by liquid chromatography-tandem mass spectrometry.

Simultaneous estimation of ibuprofen, caffeine, and paracetamol in commercial products using a green reverse-phase HPTLC method

Stability-indicating HPLC-PDA assay for simultaneous determination of paracetamol, thiamine and pyridoxal phosphate in tablet formulations

Comparative validated chromatographic methods for the simultaneous determination of caffeine, codeine, paracetamol along with the related compound "p-aminophenol" in tablets

A Chemometric–Assisted Voltammetric Method for Simultaneous Determination of Acetaminophen and Diclofenac

Simultaneous Spectrophotometric Determination in Solid Phase of Aspirin and Its Impurity Salicylic Acid in Pharmaceutical Formulations